Pharma giant Pfizer will be releasing its Q4 2017 financial results before Tuesday’s opening bell on Wall Street. The consensus recommendation for the company is “hold”, with the average consensus recommendation for the Pharmaceuticals peer group being a “buy”.    Pfizer’s EPS are expected to come in at $0.56 per share, with the average EPS […]